LIVE
President Trump and First Lady Arrive in London for State Visit
https://www.c-span.org/event/white-house-event/president-trump-and-first-lady-arrive-in-london-for-state-visit/436483
LIVE
President Trump and First Lady Arrive in London for State Visit
https://www.c-span.org/event/white-house-event/president-trump-and-first-lady-arrive-in-london-for-state-visit/436483
5:00 PM EDT
Charlie Kirk’s Alleged Killer in Court – UT v. Tyler Robinson
Law&Crime Network
Started streaming 24 minutes ago
https://www.youtube.com/watch?v=41gT0iJljkk
-
5:00 PM EDT
Charlie Kirk Murder Suspect Makes First Court Appearance
Tyler Robinson, the 22-year-old Utah man accused of killing conservative commentator Charlie Kirk, appears in court for the first time.
https://www.c-span.org/event/public-affairs-event/charlie-kirk-murder-suspect-makes-first-court-appearance/436464
>>23610585 me
embed
CDC’s Advisory Committee on Immunization Practices to Meet September 18-19
ATLANTA, GA - SEPTEMBER 12, 2025 - The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) will hold a meeting on Thursday and Friday, September 18-19, 2025, in Atlanta, GA. The ACIP comprises leading medical and public health experts to advise the CDC on the safety, effectiveness, and clinical necessity of vaccines.
When: Thursday, September 18 10 a.m. - 5 p.m. ET Friday, September 198 a.m. - 4 p.m. ET
Where: CDC Campus
https://www.cdc.gov/acip/meetings/index.html
https://www.hhs.gov/press-room/cdc-acip-meeting-september-18-19-2025.html
Draft ACIP September 18-19, 2025 Meeting Agenda (posted 9-12-2025)
https://www.cdc.gov/acip/downloads/agendas/draft-posted-2025-09-12-508.pdf
YouTube Live Stream Link 9-18-2025
https://youtube.com/live/-6uBNXsYRHQ
YouTube Live Stream Link 9-19-2025
https://youtube.com/live/_9ChY9SpPlY
Draft ACIP September 18-19, 2025 Meeting Agenda (posted 9-12-2025)
https://www.cdc.gov/acip/downloads/agendas/draft-posted-2025-09-12-508.pdf
Written Public Comments
https://www.regulations.gov/docket/CDC-2025-0454/comments